Trasylol Increases Risk of Death in Heart Surgery Patients
AP reports on an international study which found that Trasylol, a drug used to prevent bleeding during heart surgery, increases patients' risk of dying in the five years following surgery by nearly 50 percent. The researchers in the study felt that replacing the drug with less expensive drugs for a year could prevent about 10,000 deaths over the next five years.
Continue reading "Trasylol Increases Risk of Death in Heart Surgery Patients" »
